175health outcomes checked in one records studyClinicRecords study20.01.25
Veterans data maps 175 health outcomes on GLP-1 drugs, good and bad
A records study of about two million US veterans with diabetes linked GLP-1 drugs to lower risk of dozens of conditions and higher risk of some.
Amino Weekly science desk20 Jan 20251 min read
The approach
Instead of testing one question, the team asked many at once. Using US Department of Veterans Affairs health records, they compared veterans with type 2 diabetes who started a GLP-1 drug with similar veterans who started other diabetes medicines or stayed on their usual care. They followed them for an average of about three and a half years across 175 outcomes.
The map
Lower risk showed up for 42 outcomes. Among them: alcohol, cannabis and opioid use disorders, some psychotic disorders, seizures, dementia, several heart and kidney conditions, and some infections.
Higher risk showed up for 19 outcomes. Most were digestive, such as nausea, vomiting and reflux, along with low blood pressure, kidney stones, arthritis, inflammation of the pancreas and some kidney problems linked to dehydration.
Reading it carefully
A records study cannot fully separate the drug from the people who get it. The authors adjusted for hundreds of factors, but hidden differences remain possible. The group is also narrow: mostly older white men, all with diabetes.
The study works best as a list of questions for trials. The dementia result is a good example: it pointed the same way as earlier records studies, and the large semaglutide Alzheimer’s trials later found no benefit.
Source Xie Y., Choi T., Al-Aly Z., Nature Medicine, January 2025
Amino Weekly reports research. It is not medical advice and never gives doses.